Fintel reports that on September 19, 2025, JP Morgan downgraded their outlook for Replimune Group (NasdaqGS:REPL) from Neutral to Underweight. Analyst Price Forecast Suggests 110.57% Upside As of ...

Tutorial (TUT), the AI-powered education token, has surged more than 66% in the past three months, defying the broader crypto market’s recent weakness. With its ecosystem expanding through new ...

WOBURN, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

At least 187 code packages made available through the JavaScript repository NPM have been infected with a self-replicating worm that steals credentials from developers and publishes those secrets on ...

Following their recent “Long Live: The Black Parade” tour, My Chemical Romance has announced 17 new live dates to mark the 20th anniversary of their third studio album. “The Black Parade 2026” tour ...

Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...

On July 22, 2025, Replimune publicly announced that the U.S. Food and Drug Administration (FDA) had issued a "Complete Response Letter" (CRL) for its Biologics License Application (BLA) for RP1. This ...

Find out the direct holders, institutional holders and mutual fund holders for Replimune Group, Inc. (REPL).

Welcome to one of the most extensive and dynamic collections of Prompt Engineering tutorials and implementations available today. This repository serves as a comprehensive resource for learning, ...